⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Cytochem Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Cytochem Inc.
↗Montreal, Canada
Cytochem Inc. is a Montreal-based independent research laboratory that has historically specialized in molecular histology, gene expression services, and cellular genotyping. The company developed a proprietary platform for holistic gene expression mapping, including whole-body panels and in situ hybridization (ISH) services for academic, biotech, and pharmaceutical clients.
In recent years, the company has indicated a shift in its vocation. Public records suggest the company has also engaged in activities related to the medical cannabis sector, specifically micro-cultivation and medical sales, as of 2025.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Research Services / Life Sciences
SIZE & FINANCIALS
Employees:1-50
Founded:2002
Ownership:private
Status:operating
PIPELINE
Modalities:Gene expression analysis
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:University of Montreal (Collaborative research), McGill University Health Center (Collaborative research)
COMPETITION
Position:Niche Player
Competitors:CMX Research
LINKS
Website:cytochem.ca
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cytochem Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.